-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App News, Jingyou Pharmaceutical (00858.HK) announced that on October 21, 2026, the company granted share options to 3 directors (namely Dr. Xie Yi, Ms. Wang Xiujuan, and Mr. Wu Xiangyun) and 1 service provider (Dr. Mao Yumin). The share purchase rights will give the grantor the right to subscribe for 92 million shares of common shares with a face value of HK$0.01 per share in the company's share capital.

Zhitongcaijing·10/21/2026 14:50:06
Listen to the news
According to Zhitong Finance App News, Jingyou Pharmaceutical (00858.HK) announced that on October 21, 2026, the company granted share options to 3 directors (namely Dr. Xie Yi, Ms. Wang Xiujuan, and Mr. Wu Xiangyun) and 1 service provider (Dr. Mao Yumin). The share purchase rights will give the grantor the right to subscribe for 92 million shares of common shares with a face value of HK$0.01 per share in the company's share capital.